2017
DOI: 10.1016/j.bmcl.2017.02.076
|View full text |Cite
|
Sign up to set email alerts
|

Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 22 publications
0
12
0
Order By: Relevance
“…Khatri and colleagues [ 73 ] conducted a similar study, using in vitro, in vivo, and in silico studies with 2-phenyl-4,5,6,7-tetrahydro[ b ]benzothiophene derivatives as selective COX-2 inhibitors. Compounds ( 29a–d ) ( Figure 6 ) were revealed as selective COX-2 inhibitors, presenting IC 50 values in the 0.31–1.40 µM range.…”
Section: The Role Of Thiophene Derivatives In Inflammationmentioning
confidence: 99%
“…Khatri and colleagues [ 73 ] conducted a similar study, using in vitro, in vivo, and in silico studies with 2-phenyl-4,5,6,7-tetrahydro[ b ]benzothiophene derivatives as selective COX-2 inhibitors. Compounds ( 29a–d ) ( Figure 6 ) were revealed as selective COX-2 inhibitors, presenting IC 50 values in the 0.31–1.40 µM range.…”
Section: The Role Of Thiophene Derivatives In Inflammationmentioning
confidence: 99%
“…Recently, several compounds have been synthesised and evaluated as selective COX-2 inhibitors. Their common structural features involve the presence of two adjoining aryl rings attached to a central heterocyclic moiety (V-shape) with the possibility of introduction of a linker, either an ester 11 or an amide 12 , 13 , between one of the aryl rings and the central heterocycle.…”
Section: Introductionmentioning
confidence: 99%
“…In continuation of our previous study, herein, we made further modifications to our previous successfully designed anti-inflammatory quinazolinones ( I ) ( Figure 1 ), in order to increase their selectivity towards COX-2 inhibition 13 . In our current design, we kept the following: (a) the 2,3 diaryl-heterocyclic moiety (V-shape) to maintain the common structural integrity of selective COX-2 inhibitors 10 , 11 , 13 , (b) quinazolinone as the central heterocyclic ring due to its remarkable anti-inflammatory and analgesic activities 13 , 14 , and (c) the aryl ring at position 3 connected via an amide linker which may potentiate target interactions. Additionally, the introduction of the amide linker to the compounds allows for a bulkier structure, and thus, more favourable for COX-2 active site entry, which is approximately 20% larger than the COX-1 active site 12 , 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Side effects include gastrointestinal toxicity such as gastro-duodenal perforations, ulcers and bleeding, ascribed to the inhibition of cyclooxygenase-1 (COX-1). Thus, selective inhibitors of cyclooxygenase-2 (COX-2) were synthesised in an attempt to decrease these side effects [2][3][4][5][6] . Physicians would prescribe gastro-protective agents with a conventional NSAID, prior to the introduction of the COX-2 selective inhibitors.…”
Section: Introductionmentioning
confidence: 99%